SRS Capital Advisors, Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
SRS Capital Advisors, Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,122
+64.9%
67
+55.8%
0.00%0.0%
Q2 2023$4,925
+2.1%
43
+22.9%
0.00%0.0%
Q1 2023$4,825
+148.2%
35
+133.3%
0.00%
Q4 2022$1,944
-2.8%
150.0%0.00%
Q3 2022$2,000
-60.0%
15
-73.2%
0.00%
-100.0%
Q4 2021$5,0000.0%560.0%0.00%0.0%
Q3 2021$5,000
+25.0%
560.0%0.00%0.0%
Q2 2021$4,000560.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders